2.49MMarket Cap
LossP/E TTM
Creative Medical Technology Holdings Inc
Key Figures
0.746Open
0.761High
225.42KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
6.10%Turnover Ratio
0.764Prev. Close
0.674Low
118.76KTurnover
LossP/E Static
0.33P/B
0.00%Div Yield TTM
-77.91%ROA
6.25052wk High
1.40Volume Ratio
-5.49MNet Profit
3.70MShares
-2.0685EPS TTM
1.83Beta
-81.32%ROE
1.50452wk Low
11.42%Amplitude
-964.77%Gross Margin
2.49MMarket Cap
-5.90Reward/Risk
6.24%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Creative Medical Technology Holdings Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 87 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Creative Medical Technology Holdings Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Creative Medical Technology Holdings Inc Highlights
StrengthsRisks
Creative Medical Technology Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Creative Medical Technology Holdings Inc
CELZ
1
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Creative Medical Technology Holdings Inc Info
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Ticker SymbolCELZ
CompanyCreative Medical Technology Holdings Inc
CEOWarbington (Timothy)
Websitehttps://creativemedicaltechnology.com/
Shareholders
FAQs
What is the current price of Creative Medical Technology Holdings Inc (CELZ)?
The current price of Creative Medical Technology Holdings Inc (CELZ) is 0.67.
What is the symbol of Creative Medical Technology Holdings Inc?
The ticker symbol of Creative Medical Technology Holdings Inc is CELZ.
What is the 52-week high of Creative Medical Technology Holdings Inc?
The 52-week high of Creative Medical Technology Holdings Inc is 6.25.
What is the 52-week low of Creative Medical Technology Holdings Inc?
The 52-week low of Creative Medical Technology Holdings Inc is 1.50.
What is the market capitalization of Creative Medical Technology Holdings Inc?
The market capitalization of Creative Medical Technology Holdings Inc is 2.49M.
Is Creative Medical Technology Holdings Inc (CELZ) currently rated as Buy, Hold, or Sell?
According to analysts, Creative Medical Technology Holdings Inc (CELZ) has an overall rating of Buy, with a price target of 20.00.
What is the Earnings Per Share (EPS TTM) of Creative Medical Technology Holdings Inc (CELZ)?
The Earnings Per Share (EPS TTM) of Creative Medical Technology Holdings Inc (CELZ) is -2.52.